← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2016Last known activity
Aug 31, 2023
Timeline
2010s
- Jan 1, 2014
Olivia Newton-John Cancer Research Institute— Founded
Drugs by trial phase (18 distinct, 11 trials)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT05788081Lead sponsorPhase 2Aug 31, 2023
- NCT05694936CollaboratorPhase 2Jan 23, 2023
- NCT05182931Lead sponsorPhase 2Jul 14, 2022
- NCT04962126Lead sponsorPhase 2Aug 17, 2021
- NCT04969887Lead sponsorPhase 2Aug 3, 2021
- NCT04297748Lead sponsorPhase 1/Phase 2Jun 1, 2020
- NCT03610061CollaboratorPhase 1Sep 30, 2018
- NCT03647839Overall official - principal investigatorPhase 2Aug 31, 2018
- NCT03374943Lead sponsorPhase 1Dec 5, 2017
- NCT02923934Lead sponsorPhase 2Jun 1, 2017
- NCT02824965Lead sponsorPhase 1Jul 1, 2016
Details
- Founded
- Heidelberg, AU Jan 1, 2014
- Last known activity
- Aug 31, 2023